Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQR3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,467
Award facts
- Contract value 100% obligated
- $76,467.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $76,467.34 delivery order to AmerisourceBergen Drug Corp for the supply of Opdivo (nivolumab) 240 mg/24 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 23, 2025. The contract is performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's extensive portfolio of federal contracts includes a wide range of medications spanning multiple therapeutic domains, and its selection through open competition demonstrates its capability to meet federal procurement standards. This delivery order supports the Defense Health Agency and broader military healthcare operations by supplying Opdivo, a specialty immunotherapy medication used in oncology treatment protocols within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FQR3E?
SPE2DR26FQR3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FQR3E worth?
The government has obligated $76,467 on SPE2DR26FQR3E.
Is contract SPE2DR26FQR3E an order under another contract?
Yes. SPE2DR26FQR3E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR3E competed?
The extent of competition for SPE2DR26FQR3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award